Nawale Hajjaji

Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial

Philippe Bougnoux, Nawale Hajjaji, M N Ferrasson et al. · British Journal of Cancer · 2009 · 257 citations · Full text

Medicine, Oncology, Pharmacology +16

Genomics to select treatment for patients with metastatic breast cancer

Fabrice André, Thomas Filleron, Maud Kamal et al. · Nature · 2022 · 168 citations

Medicine, Bioinformatics, Oncology +12

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

Xavier Pivot, Gilles Romieu, Marc Debled et al. · The Lancet · 2019 · 128 citations

Medicine, Oncology, Breast Oncology +9

Surfaceome Proteomic of Glioblastoma Revealed Potential Targets for Immunotherapy

Mélanie Rose, Tristan Cardon, Soulaimane Aboulouard et al. · Frontiers in Immunology · 2021 · 40 citations · Full text

Medicine, Molecular Biology, Oncology +17

DHA Effect on Chemotherapy-Induced Body Weight Loss: An Exploratory Study in a Rodent Model of Mammary Tumors

Nawale Hajjaji, Charles Couet, Pierre Besson et al. · Nutrition and Cancer · 2012 · 29 citations

Medicine, Oncology, Pharmacology +15